The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy ...

So in general, really blinatumomab was very well tolerated. There were some more cytopenias in some of the patients with ...

Please provide your email address to receive an email when new articles are posted on . Results of two studies published in JAMA showed the addition of blinatumomab to consolidation chemotherapy ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Blinatumomab significantly improved disease-free survival in children with B-ALL, with a 61% increase, establishing a new standard for treatment. Hispanic children, who have higher B-ALL rates, ...

Pediatric patients with relapsed or refractory B acute lymphoblastic leukemia (B-ALL) with minimal residual disease (MRD) who were treated with blinatumomab proceeded to hematopoietic cell transplant ...

COPENHAGEN, Denmark ― Monotherapy with the novel antibody blinatumomab (Blincyto, Amgen Inc) beat standard chemotherapy, significantly improving overall survival in adult patients with ...

In a final 5-year follow-up analysis of a phase 3 trial, blinatumomab consolidation therapy demonstrated superior event-free survival and overall survival than conventional chemotherapy among children ...

KCCI EIGHT NEWS AT TEN. DES MOINES SECOND GRADER JUST CELEBRATED A MAJOR MILESTONE. KCCI LAURA TERRELL HAS THE STORY THAT WILL NO DOUBT BRING YOU JOY. GABE FULLER IS USED TO THIS ROUTINE. BY NOW.

Blina, a novel immunotherapy, proves gentler and more effective than traditional chemotherapy Portable and administered on the go, Blina allows children like Arthur to lead a more normal life during ...

Blinatumomab, developed by Micromet, is a bispecific antibody that is used to treat precursor B-cell acute lymphoblastic leukemia in both adults and children. Blinatumomab binds to CD19 on malignant B ...